Constitutive Activity in Cannabinoid Receptors-Reference-Cited by-同舟云学术

Constitutive Activity in Cannabinoid Receptors

Published:2014 Issue: Volume: Page:121-133
ISSN:1054-3589
Container-title:Pharmacology & Therapeutics of Constitutively Active Receptors
language:
Short-container-title:

Author:

Fong Tung M.

Publisher

Elsevier

Reference22 articles.

1. Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers;Bingham;British Journal of Pharmacology,2007

2. Allostery and the Monod-Wyman-Changeux model after 50 years;Changeux;Annual Review of Biophysics,2012

3. Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase;Cioffi;Journal of Cell Biology,2002

4. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor;De Lean;Journal of Biological Chemistry,1980

5. Isolation and structure of a brain constituent that binds to the cannabinoid receptor;Devane;Science,1992

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years;Pharmacological Reviews;2023-05-10

2. Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model;Molecular and Cellular Neuroscience;2022-03

3. Overview of the Endocannabinoid System and Endocannabinoidome;Cannabis and Cannabinoid-Based Medicines in Cancer Care;2022

4. δ Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects;Current Topics in Medicinal Chemistry;2020-12-03

5. Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development;Current Topics in Medicinal Chemistry;2019-09-16